The EMA has lifted restrictions on the chikungunya vaccine in people 65 and older, while warning that it should be used only ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 ...

Controversial precautionary rules imposed last year for prescribing valproate to potentially fertile males are being assessed ...

Valneva ( ($VALN) ) just unveiled an update. On July 11, 2025, Valneva announced that the European Medicines Agency (EMA) lifted the temporary ...

The offer-for-sale (OFS), priced between ₹ 540 and ₹ 570 per share, marks a key milestone for the company, which has ...

An experimental drug, Elinzanetant, has shown promise in reducing menopause symptoms in breast cancer patients undergoing ...

An updated edition of the June 4, 2025 article. The world is in the midst of a historic demographic shift with populations ...

Pharmexcil urges member exporters to respond to Mauritius medicine requirement: Shardul Nautiyal, Mumbai Saturday, July 12, 2025, 08:00 Hrs [IST] The Pharmaceuticals Export Promot ...

(Reuters) -The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased by an experimental non-hormonal drug being developed by Bayer, ...

Gland Pharma said that its Pashamylaram facility has received certificate of good manufacturing practices (GMP) compliance from Danish Medicines Agency.

SAN DIEGO, CA, USA I July 11, 2025 I Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based ...

Bayer receives UK MHRA approval for Lynkuet to treat moderate to severe vasomotor symptoms associated with menopause: Berlin Saturday, July 12, 2025, 10:00 Hrs [IST] Bayer announc ...